Drug
quetiapine fumarate XR
quetiapine fumarate XR is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Phase Distribution
Ph phase_3
2
50%
Ph phase_4
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (50.0%)
Phase 42 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
NCT00883493
completedphase_4
Adult Bipolar Mania
NCT00931723
completedphase_4
Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)
NCT00779506
completedphase_3
Generalized Anxiety Disorder Adjunct Study
NCT00534599
Clinical Trials (4)
Showing 4 of 4 trials
NCT00883493Phase 3
Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
NCT00931723Phase 4
Adult Bipolar Mania
NCT00779506Phase 4
Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)
NCT00534599Phase 3
Generalized Anxiety Disorder Adjunct Study
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4